Relay Therapeutics Inc Sustainability Reports
Relay Therapeutics, Inc. operates as a clinical-stage precision medicine company. The company utilizes its Dynamo platform to discover and develop small molecule therapies for targeted oncology and genetic diseases.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
ISIN: US75943R1023
8 reports from 2020 to 2025